DICE
DICE Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
J. Kevin Judice
IPO Date
2021-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
DICE Therapeutics, Inc.
CEO
J. Kevin Judice
IPO Date
2021-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $17.00 |
| 9 Aug 2023 | TETLOW SHARON | director | D-Return | Disposed | 21,250 | $14.98 |
| 9 Aug 2023 | SCHELLER RICHARD H | director | D-Return | Disposed | 8,427 | $0.00 |
| 9 Aug 2023 | SCHELLER RICHARD H | director | D-Return | Disposed | 22,600 | $17.00 |
| 9 Aug 2023 | SCHELLER RICHARD H | director | D-Return | Disposed | 31,250 | $14.98 |
| 9 Aug 2023 | RA CAPITAL MANAGEMENT, L.P. | — | U-Tender | Disposed | 786,407 | $0.00 |
| 9 Aug 2023 | RA CAPITAL MANAGEMENT, L.P. | — | D-Return | Disposed | 21,250 | $14.98 |
| 9 Aug 2023 | Scopa James Paul | director | D-Return | Disposed | 25,722 | $0.00 |
| 9 Aug 2023 | Scopa James Paul | director | D-Return | Disposed | 13,800 | $17.00 |